TY - JOUR
T1 - ASCCP Colposcopy Standards
T2 - Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice
AU - Khan, Michelle J.
AU - Werner, Claudia L.
AU - Darragh, Teresa M.
AU - Guido, Richard S.
AU - Mathews, Cara
AU - Moscicki, Anna Barbara
AU - Mitchell, Martha M.
AU - Schiffman, Mark
AU - Wentzensen, Nicolas
AU - Massad, L. Stewart
AU - Mayeaux, E. J.
AU - Waxman, Alan G.
AU - Conageski, Christine
AU - Einstein, Mark H.
AU - Huh, Warner K.
N1 - Funding Information:
1Departments of Obstetrics and Gynecology, and Adult and Family Medicine, Kaiser Permanente Northern California, San Leandro, CA; 2Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX; 3Department of Pathology, University of California, San Francisco, CA; 4Magee Women's Hospital of the UPMC System, Pittsburgh, PA; 5Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Alpert Medical School, Brown University, Providence, RI; 6Department of Pediatrics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA; 7Department of Gynecologic Oncology, Yale University, New Haven, CT; 8Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; 9Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University of Medicine, St Louis, MO; 10Department of Family and Preventive Medicine, Department of Obstetrics and Gynecology, University of South Carolina School of Medicine, Columbia, SC; 11Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, Albuquerque, NM; 12Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO; 13Department of Obstetrics, Gynecology and Women's Health, Rutgers New Jersey Medical School, Newark, NJ; and 14Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham School of Medicine, Birmingham, AL Correspondence to: Michelle J. Khan, MD, MPH, Departments of Obstetrics and Gynecology, and Adult and Family Medicine, Kaiser Permanente Northern California, 2500 Merced St. Suite 320, San Leandro, CA 94577. E-mail: Michelle.J.Khan@kp.org Logistical and meeting support for this project was provided by American Society for Colposcopy and Cervical Pathology. Drs Mayeaux, Khan, Huh, Wentzensen, Massad, Waxman, and Conageski report no conflicts of interest. Dr Einstein has advised, but does not receive an honorarium from any companies. In specific cases, his employer has received payment for his consultation from Photocure, Papivax, Inovio, PDS Biotechnologies, Natera, and Immunovaccine. If travel is required for meetings with any industry, the company pays for Dr Einstein's travel-related expenses. Moreover, his employers have received grant funding for research-related costs of clinical trials that Dr Einstein has been the overall Principal Investigator or local Principal Investigator for the past 12 months from Astra Zeneca, Baxalta, Pfizer, Inovio, Fujiboro, and Eli Lilly. No institutional review board approval or written consent was required because the research was literature based and did not involve human subjects. Role of the Funding Source: Logistical and meeting support for this project was provided by ASCCP. © 2017, American Society for Colposcopy and Cervical Pathology DOI: 10.1097/LGT.0000000000000338 Results: Colposcopy is used in the evaluation of abnormal or inconclusive cervical cancer screening tests. Colposcopy aids the identification of cervical precancers that can be treated, and it allows for conservative management of abnormalities unlikely to progress. The potential harms of colposcopy include pain, psychological distress, and adverse effects of the procedure. A comprehensive colposcopy examination should include documentation of cervix visibility, squamocolumnar junction visibility, presence of acetowhitening, presence of a lesion(s), lesion (s) visibility, size and location of lesions, vascular changes, other features of lesion(s), and colposcopic impression. Minimum criteria for reporting include squamocolumnar junction visibility, presence of acetowhitening, presence of a lesion(s), and colposcopic impression. Conclusions: A recommended terminology for use in US colposcopic practice was developed, with comprehensive and minimal criteria for reporting.
Publisher Copyright:
© Lippincott Williams & Wilkins.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Objectives The American Society for Colposcopy and Cervical Pathology Colposcopy Standards address the role of and approach to colposcopy and biopsy for cervical cancer prevention in the United States. Working Group 1 was tasked with defining the role of colposcopy, describing benefits and potential harms, and developing an official terminology. Methods A systematic literature review was performed. A national survey of American Society for Colposcopy and Cervical Pathology members provided input on current terminology use. The 2011 International Federation for Cervical Pathology and Colposcopy terminology was used as a template and modified to fit colposcopic practice in the United States. For areas without data, expert consensus guided the recommendation. Draft recommendations were posted online for public comment and presented at an open session of the 2017 International Federation for Cervical Pathology and Colposcopy World Congress for further comment. All comments were considered for the final version. Results Colposcopy is used in the evaluation of abnormal or inconclusive cervical cancer screening tests. Colposcopy aids the identification of cervical precancers that can be treated, and it allows for conservative management of abnormalities unlikely to progress. The potential harms of colposcopy include pain, psychological distress, and adverse effects of the procedure. A comprehensive colposcopy examination should include documentation of cervix visibility, squamocolumnar junction visibility, presence of acetowhitening, presence of a lesion(s), lesion(s) visibility, size and location of lesions, vascular changes, other features of lesion(s), and colposcopic impression. Minimum criteria for reporting include squamocolumnar junction visibility, presence of acetowhitening, presence of a lesion(s), and colposcopic impression. Conclusions A recommended terminology for use in US colposcopic practice was developed, with comprehensive and minimal criteria for reporting.
AB - Objectives The American Society for Colposcopy and Cervical Pathology Colposcopy Standards address the role of and approach to colposcopy and biopsy for cervical cancer prevention in the United States. Working Group 1 was tasked with defining the role of colposcopy, describing benefits and potential harms, and developing an official terminology. Methods A systematic literature review was performed. A national survey of American Society for Colposcopy and Cervical Pathology members provided input on current terminology use. The 2011 International Federation for Cervical Pathology and Colposcopy terminology was used as a template and modified to fit colposcopic practice in the United States. For areas without data, expert consensus guided the recommendation. Draft recommendations were posted online for public comment and presented at an open session of the 2017 International Federation for Cervical Pathology and Colposcopy World Congress for further comment. All comments were considered for the final version. Results Colposcopy is used in the evaluation of abnormal or inconclusive cervical cancer screening tests. Colposcopy aids the identification of cervical precancers that can be treated, and it allows for conservative management of abnormalities unlikely to progress. The potential harms of colposcopy include pain, psychological distress, and adverse effects of the procedure. A comprehensive colposcopy examination should include documentation of cervix visibility, squamocolumnar junction visibility, presence of acetowhitening, presence of a lesion(s), lesion(s) visibility, size and location of lesions, vascular changes, other features of lesion(s), and colposcopic impression. Minimum criteria for reporting include squamocolumnar junction visibility, presence of acetowhitening, presence of a lesion(s), and colposcopic impression. Conclusions A recommended terminology for use in US colposcopic practice was developed, with comprehensive and minimal criteria for reporting.
KW - benefits
KW - potential harms
KW - role of colposcopy
KW - terminology
UR - http://www.scopus.com/inward/record.url?scp=85040784351&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040784351&partnerID=8YFLogxK
U2 - 10.1097/LGT.0000000000000338
DO - 10.1097/LGT.0000000000000338
M3 - Article
C2 - 28953110
AN - SCOPUS:85040784351
SN - 1089-2591
VL - 21
SP - 223
EP - 229
JO - Journal of Lower Genital Tract Disease
JF - Journal of Lower Genital Tract Disease
IS - 4
ER -